Sign In
Buy MNKD
$3.36
-0.0700 (-2.04%)
At Close: Jun 03, 2026
NEW YORK, Nov. 10, 2020 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty
MannKind Corporation (MNKD) CEO Michael Castagna on Q3 2020 Results - Earnings Call Transcript
10:45pm, Wednesday, 04'th Nov 2020
MannKind Corporation (MNKD) CEO Michael Castagna on Q3 2020 Results - Earnings Call Transcript
MannKind Corporation Reports 2020 Third Quarter Financial Results
04:00pm, Wednesday, 04'th Nov 2020
Conference Call to Begin Today at 5:00 PM ET
MannKind: Global Product Sales, Late-Stage Clinical Pipeline Candidate, And Strong Leadership, 34% Upside
04:11pm, Tuesday, 03'rd Nov 2020
MannKind Corporation is a biopharma company focused on developing and commercializing inhaled therapeutics for endocrinology and lung diseases. Mannkind has one FDA-approved inhalable insulin formulat
MannKind Corporation to Hold 2020 Third Quarter Financial Results Conference Call on November 4, 2020
08:00am, Thursday, 29'th Oct 2020
WESTLAKE VILLAGE, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) will release its 2020 third quarter financial results and its management will host a conference call to d
Stock’s Volume Buzz: MannKind Corporation (NASDAQ:MNKD), Bridgeline Digital, Inc. (NASDAQ:BLIN) - Stocks Equity
12:36pm, Saturday, 26'th Sep 2020
MannKind Corporation (NASDAQ:MNKD) with the stream of 1.09% also noticed, India Bridgeline Digital, Inc. (NASDAQ:BLIN) encountered a rapid change of -1.59% in the last hour of Friday’s trading sessi
An In-Depth Look At vTv Therapeutics (NASDAQ:VTVT)
04:05pm, Wednesday, 16'th Sep 2020
Today, we provide an in depth look at vTv Therapeutics. The company is developing two primary compounds.
MannKind Corporation's (MNKD) CEO Michael Castagna at H.C. Wainwright 2second Annual Global Investment Conference (Transcript)
09:28pm, Monday, 14'th Sep 2020
MannKind Corporation (NASDAQ:MNKD) H.C. Wainwright 2second Annual Global Investment Conference September 14, 2020, 3:30 pm ET Executives Michael Castagna - Chief Executive Officer Analysts Oren Livnat
Glistering Stock: MannKind Corporation (NASDAQ:MNKD), Volt Information Sciences, Inc. (AMEX:VOLT) - Stocks Equity
03:48am, Friday, 11'th Sep 2020
MannKind Corporation (NASDAQ:MNKD) with the stream of 0.61% also noticed, India Volt Information Sciences, Inc. (AMEX:VOLT) encountered a rapid change of 4.79% in the last hour of Thursday’s trading
326,000 Shares in MannKind Co. (NASDAQ:MNKD) Acquired by Skandinaviska Enskilda Banken AB publ
06:38am, Thursday, 10'th Sep 2020
Skandinaviska Enskilda Banken AB publ purchased a new stake in MannKind Co. (NASDAQ:MNKD) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchas
MannKind Corporation to Participate in BTIG Virtual Biotechnology Conference 2020
09:00pm, Friday, 07'th Aug 2020
WESTLAKE VILLAGE, Calif., Aug. 07, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients
Oppenheimer Releases a Buy Rating on MannKind (MNKD) - Markets
02:51pm, Thursday, 06'th Aug 2020
In a report released today, Steven Lichtman from Oppenheimer assigned a Buy rating to MannKind (MNKD – Research Report), with
MannKind (MNKD) Reports Q2 Loss, Misses Revenue Estimates
10:35pm, Wednesday, 05'th Aug 2020
MannKind (MNKD) delivered earnings and revenue surprises of 0.00% and -0.52%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
MannKind Corporation Reports 2020 Second Quarter Financial Results
08:00pm, Wednesday, 05'th Aug 2020
Conference Call to Begin Today at 5:00 PM ET * 2Q 2020 Afrezza Net Revenue of $7.0 million; +15% vs. 2Q 2019 * 1H 2020 Afrezza Net Revenue of $15.0 million; +35% vs. 1H 2019 * Cash and cash equiv
FY2020 EPS Estimates for MannKind Co. (NASDAQ:MNKD) Lifted by SVB Leerink
02:14am, Sunday, 02'nd Aug 2020
MannKind Co. (NASDAQ:MNKD) – Equities researchers at SVB Leerink upped their FY2020 earnings estimates for MannKind in a report issued on Wednesday, July 29th. SVB Leerink analyst T. Smith now forec
